NCT04851119 Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT04827953 Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04802993 Survival Among Patients With Pancreatic Cancer Depending on Surgical Resection Rate Status COMPLETED Phase N/A
NCT04797676 Effects of Different Methods of PDAC Specimen Acquisition on Primary Cell Culture and Application Status UNKNOWN Phase N/A
NCT04794140 A Clinical Study to Evaluated Which Number of Passes of EUS-FNB is Better for Culturing Primary Cells of PDAC Status UNKNOWN Phase NA
NCT04793633 Evaluating LINFU™: A Noninvasive Method for Collecting Pancreatic Cells for the Early Detection of Pancreatic Cancer Status ENROLLING_BY_INVITATION Phase N/A
NCT04779151 Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab Status TERMINATED Phase PHASE2
NCT04752696 Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma Status COMPLETED Phase PHASE2
NCT04740164 A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP Status COMPLETED Phase NA
NCT04726956 A Combination of AKR1B10 and CA19-9 Improves the Diagnosis of PDAC Status COMPLETED Phase N/A
NCT04712721 Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins. Status TERMINATED Phase EARLY_PHASE1
NCT04692740 Chlorambucil in Metastatic PDAC Patients Bearing a Germ Line DNA Defects Repair Mutations (SALE Trial) Status UNKNOWN Phase PHASE2
NCT04662112 Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT04657068 A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT04634539 Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT04632199 Study to Assess the Safety and Efficacy of Intravenous Injection of the Imaging Agent 111In-IPN01087 in Patients With Locally Advanced or Metastatic Pancreatic or Colorectal Cancer. Status WITHDRAWN Phase PHASE1
NCT04580485 INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors Status COMPLETED Phase PHASE1